Alport syndrome is very similar to hereditary nephritis. There may be nerve deafness and congenital eye abnormalities associated with Alport syndrome. The cause is a mutation in a gene for collagen. The disorder is uncommon, and most often affects males since the genetic defect is typically found on the X chromosome.

In women, the disorder is usually mild, with minimal or no symptoms. Women can transmit the gene for the disorder to their children, even if the woman has no symptoms of the disorder. In men, the symptoms are more severe and progress faster.

The disorder causes chronic glomerulonephritis with destruction of the glomeruli. Initially, there are no symptoms. Progressive destruction of the glomeruli causes blood in the urine and decreases the effectiveness of the kidney's filtering system.

There is progressive loss of kidney function and accumulation of fluids and wastes in the body, with eventual progression to end-stage renal (kidney) disease at an early age. ESRD, caused by Alport syndrome, often develops between adolescence and age 40.

Risk factors include having a family history of Alport syndrome, nephritis, end-stage renal disease in male relatives, hearing loss before age 30, bloody urine, glomerulonephritis, and similar disorders.

• Abnormal urine color
• Blood in the urine
• Loss of hearing, more common in males
• Decrease or loss of vision, more common in males
• Cough
• Ankle, feet, and leg swelling
• Swelling, overall
• Swelling around the eyes

• Urinalysis shows blood, protein, and other abnormalities.
• BUN, creatinine are elevated.
• Red blood cell count, hematocrit may decrease.
• Hematuria test is positive.
• Audiometry may show nerve deafness.
• Renal biopsy shows chronic glomerulonephritis with the classical changes of Alport syndrome.

• Chronic renal failure
• End-stage renal disease
• Permanent deafness
• Decrease or loss of vision